Twenty-one people were scanned again about a year after their original treatment course: Each was imaged by MRI or CT at a mean of 332.6 plus or minus 88.5 days, and the scans were read by a blinded radiologist against the same person's baseline and six-week images.
Compared with baseline, abdominal fat thickness was 14.63 per cent lower — just under 3 mm — muscle thickness was 19.05 per cent higher, about 1.9 mm, and the separation between the abdominal muscles was 10.46 per cent smaller, about 2 mm. All were statistically significant, and none was related to weight change.
Four things about that study decide how much weight it can carry: It had 21 people. It had no control group, so there is nothing to compare the year's drift against. Both authors declare BTL medical advisory relationships in other publications, though the paper carries no conflict statement. And the authors themselves wrote that their finding "needs to be verified by continuing follow-up of this group and by further studies" — which has not happened.
It is real published evidence and it is the best available. It is not the same as knowing the result lasts a year in general.
Six months is where most of this literature stops, and the phrasing at that point is worth reading closely.
A postpartum pilot of 10 women, 9 imaged at six months by MRI, reported fat 17.6 per cent lower, muscle 21.7 per cent higher and the muscle gap 23.2 per cent smaller at that visit.
The EmSculpt NEO abdominal study of 41 people reported only that "six-month data showed maintenance of these outcomes", without giving the numbers.
The one randomised sham-controlled trial reported that improvements "were maintained at 6 months after treatment in the active group".
A lateral-thigh study reported results maintained at six months.
A study of visceral fat after EmSculpt NEO reported a 17.8 per cent reduction at three months and 17.3 per cent at six.
An ultrasound study of arms and calves reported that results "peaked at 3 months and were sustained up to 6 months with a slight but insignificant decline".
The last one is the most informative sentence in the group, because it describes a trajectory rather than a verdict. The measurements peak, then start to drift back. Whether the drift continues, flattens or accelerates after six months is not something anyone has measured except in that single 21-person study.
This is the part that does not depend on anyone's study, and it is the honest core of the question.
The treatment works by making a muscle contract: It does not install anything, remove anything permanently from the muscle, or change how the muscle is wired. Whatever adaptation follows is the same kind of adaptation that follows any training stimulus — and skeletal muscle holds adaptation only for as long as the stimulus keeps arriving. Stop training a muscle and it reverts toward its untrained state over weeks to months.
Four sessions over two weeks is a short course of stimulus. Nothing about the device suspends the biology that applies to every other form of muscle training. If you do nothing afterwards, the reasonable expectation is decline. If you train the same area, you are supplying the stimulus yourself, and it becomes impossible to say which result belongs to which cause.
That is also why the durability question has no single answer. What lasts depends on what you do next, and no study has tracked participants' activity afterwards.
The fat side of EmSculpt NEO is a different question with different physiology, and it is worth separating. Fat reduction in that device comes from its radiofrequency clearances, not from the muscle stimulation. Nothing about the treatment prevents fat returning if you gain weight, and the trials cannot help you here: one systematic review of 15 HIFEM studies found that not one of them reported participants' weight change before and after treatment. If weight is not recorded, a result cannot be separated from an ordinary few pounds lost or gained.
An independent systematic review of 14 electromagnetic body-contouring studies — its author declares no industry ties — reaches a different conclusion from the clinic version of durability.
It found a mean fat thickness reduction of 5.5 mm and a mean muscle thickness increase of 2.2 mm across the studies, with the narrowing of the muscle gap at 2.9 mm and not statistically significant. On mechanism, it argues: "muscle hypertrophy is not known to occur acutely after exercise; muscle swelling likely accounts for an early increment in muscle thickness. Any improvement in the diastasis recti is likely fictitious." Its overall verdict is that "the evidence for efficacy is tenuous" and that conflict of interest and publication bias are major factors.
Take that argument seriously and it predicts short durability, because swelling resolves. The 21-person one-year data set is the main published counter-argument, since swelling does not persist for eleven months. Both things are on the record and a reader deciding whether to buy a package deserves both.
One structural caveat on the critic as well: he is a practising liposuction surgeon whose reviews consistently conclude that liposuction remains the gold standard. No industry money, but not a disinterested position either.
Clinics commonly recommend one session every three to six months to preserve the result, and consumer aggregators repeat the same interval.
No published study evaluates maintenance sessions: There is no trial that randomised people to maintenance or no maintenance, no prospective cohort that followed both groups, and no comparison of intervals. The three-month and six-month numbers are not derived from measured decline curves, because those curves have not been published either.
That does not make maintenance pointless. If the effect behaves like training, periodic stimulus is a reasonable thing to do, and it is exactly what you would predict from the physiology. But it is reasoning, not evidence, and it should be priced as such — a recurring cost with no measured benefit attached to the specific schedule being sold.
Four questions do most of the work when a durability claim is put in front of you.
Which study is that number from, and how long did it run?: If the answer is "a year", there is one study of 21 people, and it is fair to ask whether that is the one being quoted.
Was there a control group?: For everything except one sham-controlled trial, the answer is no.
Does the price include maintenance, and on what schedule?: Then ask what the schedule is based on. There is no published answer.
What am I going to do with the area afterwards?: This is the variable with the largest effect on the outcome and the only one you control.
No EmSculpt or EmSculpt NEO clearance states a duration of effect: Some device categories do carry durability wording in their cleared indications — cellulite devices are cleared with explicit observation periods written into the indication — but nothing in this family does. A clinic claim about how long results last is therefore not a regulatory claim and has no labelling behind it.